With a new insight into a model of Parkinson's disease, researchers from the University of Pennsylvania School of Veterinary Medicine have identified a novel target for mitigating some of the disease's toll on the brain.

Last March, researchers at UCLA reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson's disease from binding together and killing the brain's neurons.

Scientists have developed a unique compound that in laboratory tests blocks inflammation-causing molecules in blood cells known to fuel ailments like cancer and cardiovascular disease without causing harmful toxicity.

Traditional cigarettes pose a well-established risk to smokers' health, but the effects of electronic cigarettes are still being determined. Helping to flesh out this picture, researchers are reporting in the ACS journal ...

(Medical Xpress)—Just because something is marketed as herbal doesn't make it healthy—especially when it comes to smoking shisha, which can contain toxic metals, tar and other carcinogenic compounds sometimes on par with ...

Researchers from Brigham and Women's Hospital (BWH) have developed a risk score calculation that can help predict which patients with rhabdomyolysis (a condition that occurs due to muscle damage) may be at risk for the severe ...

Milk from organic farms has a lower concentration of elements like zinc, iodine and selenium than milk produced by conventional farming methods. The discrepancy is due to the absence of mineral substances in the diets of ...

A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from ...